Sandamali, J. A. N.; Hewawasam, R. P.; Jayatilaka, K. A. P. W.
(Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka, 2018-11-08)
Background: Doxorubicin is one of the most potent and widely used chemotherapeutic
agents. However, clinical utility is limited by dose-dependent cardiotoxicity, which leads to
severe heart failure. Previous studies ...